The Beltway-based biopharma disputed the FDA’s conclusions regarding the data provided in its supplemental application for ...

At press time, PUMP traded at $0.002754, down 3.85% daily and 30.4% monthly, reflecting sustained selling pressure. That weakness coincided with visible capitulation from large holders. On-chain data ...

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff came ...

Institutional Shares underperformed its benchmark, the Russell 2000 Value Index (net), during the quarter. Read more here.

UBS stock analysis: hold ratings, 2026 investment banking upside, wealth demand, dividends for US investors, valuation risks ...

Q1 2026 Earnings Call Transcript January 7, 2026 MSC Industrial Direct Co., Inc. beats earnings expectations. Reported EPS is ...

A group of tech executives, app developers and Silicon Valley philosophers is seeking to streamline the messy matters of the ...

Q2 2026 Earnings Call Transcript January 6, 2026 AAR Corp. beats earnings expectations. Reported EPS is $1.18, expectations ...

AAA State of Play leaders know health and inclusivity are goals that are both critically important and wider than most ...

The long-awaited opening of The Zone at the Northwest Arena is coming later this year. Arena officials have been long working ...

As a tech explorer and author of the Wonder Tools newsletter, I’ve tested more than 200 Ed Tech services this year in search ...